speb/financial-data huggingface dataset:
TATACHEM.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 76160000000.00
TATACHEM.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 760000000.00
TATACHEM.NS balance_sheet (annual, 2022-03-31) — Work In Process: 1860000000.00
TATACHEM.NS income_statement (annual, 2022-03-31) — Write Off: 180000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — +Operating Expense: 95400000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — +Total Revenue: 166800000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 25970000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 26270000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -39700000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 12590000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -950000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Amortization: 1090000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 1090000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 40000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 48990000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 254756278.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Basic EPS: 90.95
TATACHEM.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 7620000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 16360000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -15780000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 2130000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 2550000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 5080000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 19160000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -3190000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 3150000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 1930000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -2370000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Change In Payable: 670000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -5090000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -6790000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -2910000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Common Stock: 2550000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -3190000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 197210000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 24910000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 41490000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Current Assets: 81640000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 760000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Current Debt: 5430000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 6190000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 49040000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 3520000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Defined Pension Benefit: 500000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Depreciation: 7830000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 8920000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 8920000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 7830000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Derivative Product Liabilities: 230000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 254756278.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Diluted EPS: 90.95
TATACHEM.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 23170000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 190000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 1320000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — EBIT: 30650000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — EBITDA: 39570000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 370000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — End Cash Position: 5080000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Financial Assets: 80000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1500000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -20760000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 8730000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 13930000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -1000000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 1050000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Goodwill: 21550000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 105300000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 27220000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 130300000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Gross Profit: 125310000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Hedging Assets Current: 220000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Interest Expense: 3250000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 3250000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Interest Income: 750000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 750000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -3440000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 480000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Inventory: 25320000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 258040000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -11860000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 520000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 50490000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Investmentsin Joint Venturesat Cost: 11360000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 38920000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 3520000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 1370000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 55400000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 56770000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 38920000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -50870000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 11360000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 14540000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 82020000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 9210000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Minority Interests: -1170000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Net Debt: 55750000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 300000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Net Income: 23170000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 23170000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 24520000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Net Income Discontinuous Operations: -180000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 23170000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 23350000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 27220000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 24340000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Net Interest Income: -3310000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 1120000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -11950000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -11950000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -3310000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 10000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 3910000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Net PPE: 90600000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -15440000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 91910000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 3640000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 1440000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 19350000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 8730000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 39220000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Normalized Income: 23036788321.17
TATACHEM.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 29710000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Operating Income: 29910000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Operating Revenue: 166800000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 254756278.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 2570000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 370000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 194660000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 83750000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 3720000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 180000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 600000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 360000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 42630000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Other Payable: 5330000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Other Properties: 850000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 6160000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 14080000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Other Special Charges: 190000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Payables: 32680000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: 820000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 1710000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Pretax Income: 27400000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Properties: 2640000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 90000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -46740000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -15780000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 14560000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 41490000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 8920000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 500000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 500000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -50870000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 190000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 95820000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 47860000000.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 340000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 26420000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 27470000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Share Issued: 254756278.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Special Income Charges: -220000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 197210000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 91910000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 36788321.17
TATACHEM.NS income_statement (annual, 2023-03-31) — Tax Provision: 2880000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.11
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 0.00
TATACHEM.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -4070000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Total Assets: 350840000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 252610000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Total Debt: 62960000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 206420000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Total Expenses: 136890000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 144420000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 269200000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 95380000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 810000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 1190000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 350000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 350000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Work In Process: 2030000000.00
TATACHEM.NS balance_sheet (annual, 2023-03-31) — Working Capital: 32600000000.00
TATACHEM.NS income_statement (annual, 2023-03-31) — Write Off: 30000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — +Operating Expense: 97850000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — +Total Revenue: 153020000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 23690000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 19000000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -54440000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 12590000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -1080000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Amortization: 1130000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 1130000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 90000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 74910000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 254756278.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Basic EPS: 10.52
TATACHEM.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 5080000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 18790000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -18340000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 4990000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 2550000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 4250000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 12420000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -4470000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 3860000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 390000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -230000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Change In Payable: -4560000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 8110000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 3320000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -880000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Common Stock: 2550000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -4470000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 222410000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 22890000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 35800000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Current Assets: 63670000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 1080000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Current Debt: 21660000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 22740000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 60550000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 2330000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Defined Pension Benefit: 430000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Depreciation: 8670000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 9800000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 9800000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 8670000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Derivative Product Liabilities: 260000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 254756278.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Diluted EPS: 10.52
TATACHEM.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 2680000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 180000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 1850000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — EBIT: 12600000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — EBITDA: 22400000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 50000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — End Cash Position: 4250000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Financial Assets: 10000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1500000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -24940000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 10700000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 11820000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -860000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 1230000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Goodwill: 21890000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 105990000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 20080000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 149950000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Gross Profit: 117220000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Hedging Assets Current: 150000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 9470000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Interest Expense: 4300000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 4300000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Interest Income: 1410000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 1410000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -4460000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 640000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Inventory: 25240000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 273050000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -6100000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 520000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 76410000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Investmentsin Joint Venturesat Cost: 14910000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 1660000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 3620000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 3910000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 28980000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 32890000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 1660000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -13150000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 14910000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 14650000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 100870000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 8730000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Minority Interests: -1670000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Net Debt: 46390000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 470000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Net Income: 2680000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 2680000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 4490000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Net Income Discontinuous Operations: -140000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 2680000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 2820000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 8160000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 4350000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Net Interest Income: -3890000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 7030000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -11490000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -11490000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -3890000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -2080000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -640000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Net PPE: 95510000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -18230000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 1660000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 116420000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 3410000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 450000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 23750000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 850000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 30720000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Normalized Income: 8644000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 30160000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Operating Income: 19370000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Operating Revenue: 153020000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 254756278.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 1160000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 190000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 219860000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 84100000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 3060000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 220000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 590000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 440000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 42280000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Other Payable: 5730000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Other Properties: 1100000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 3060000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 8170000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Other Special Charges: -930000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Payables: 29930000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Pension And Employee Benefit Expense: 670000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 2120000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Pretax Income: 8300000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Properties: 2680000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 230000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -38300000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -18340000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 12590000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 35800000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 9800000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 420000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 420000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -13150000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 180000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 92580000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 45330000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 110000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 26630000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 27860000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Share Issued: 254756278.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 1660000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Special Income Charges: -8810000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 222410000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 116420000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -2496000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Tax Provision: 3810000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.30
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 250000000.00
TATACHEM.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -3870000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Total Assets: 367560000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 251390000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Total Debt: 55630000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 231140000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Total Expenses: 133650000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 136420000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 303890000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 75870000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 1000000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 330000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -8320000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -8320000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Work In Process: 1950000000.00
TATACHEM.NS balance_sheet (annual, 2024-03-31) — Working Capital: 3120000000.00
TATACHEM.NS income_statement (annual, 2024-03-31) — Write Off: 270000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 22670000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 21420000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Assets Held For Sale Current: 30000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 78790000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 6520000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 2550000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 4500000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 12810000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 2550000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 221950000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 21200000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 63900000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 980000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 21380000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 22360000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 56930000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 2480000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 22140000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 106420000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 100610000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 23490000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 280220000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Investment Properties: 510000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 78790000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 5540000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 36890000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 42430000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 14660000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 14690000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 9160000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 53770000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 100610000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 115530000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 450000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 25910000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Non Current Prepaid Assets: 8890000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 254756278.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 5860000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 2720000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 219400000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 84280000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 1980000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 4130000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 79410000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 8310000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Payables: 23210000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 254756278.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 221950000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 115530000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 290000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 376210000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 258840000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 64790000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 231110000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 145100000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 312310000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 88170000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 540000000.00
TATACHEM.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 6970000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 29220000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 35900000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 254807692.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Basic EPS: -2.08
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 5140000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 2800000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 2800000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 254807692.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: -2.08
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -530000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — EBIT: 1440000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — EBITDA: 4240000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 30760000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 1480000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 1480000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Minority Interests: -320000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Net Income: -530000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -530000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -210000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Net Income Discontinuous Operations: 0.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -530000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -530000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -210000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -1480000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -1480000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 4940000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Normalized Income: -40000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Operating Income: 1540000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 35900000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 280000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 14700000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Pretax Income: -40000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 5140000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 2800000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 6450000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Selling General And Administration: 6450000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: -700000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: -210000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 170000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.30
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 34360000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: -700000000.00
TATACHEM.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -700000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — +Operating Expense: 102680000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 27660000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — +Total Revenue: 147750000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 35090000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 25100000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 25100000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 19000000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 19000000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -63970000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -63970000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 12590000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 12590000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1200000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1200000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Amortization: 1280000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 1280000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Assets Held For Sale Current: 0.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 0.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 68680000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 68680000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 254756278.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 255707763.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Basic EPS: 9.23
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Basic EPS: -2.19
TATACHEM.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 4250000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 22600000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 22600000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -20050000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 7680000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 7680000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 2550000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2550000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 5480000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 5480000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 14010000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 14010000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -3820000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 3470000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 3470000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 2010000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 2010000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -340000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Change In Payable: -480000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -920000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -1740000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 1090000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Common Stock: 2550000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 2550000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -3820000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 215940000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 215940000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 20030000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 20030000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 36750000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 7090000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Current Assets: 67200000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 67200000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 1180000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1180000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Current Debt: 21380000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 21380000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 22560000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 22560000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 61390000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 61390000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 2920000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 2920000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Defined Pension Benefit: 150000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Defined Pension Benefit: 150000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Depreciation: 9950000000.00
TATACHEM.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 11230000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 11230000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 2930000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 9950000000.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 2930000000.00
TATACHEM.NS balance_sheet (annual, 2025-03-31) — Derivative Product Liabilities: 110000000.00
TATACHEM.NS balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 110000000.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 254756278.00
TATACHEM.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 255707763.00
TATACHEM.NS income_statement (annual, 2025-03-31) — Diluted EPS: 9.23